Express scripts cut a deal with ABBV over their hep C drug. This made GILD drop 14% in on month (DEC). This was the first time in history something like this happened and an exclusive deal was cut.

I believe this took Express scripts eyes off the compounding sector. I believe the pendulum is swinging in our favor rather than against us.